1-4 of 4
John M. Hill, Jr.
Close
Sort by
Journal Articles

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Christi Ann Hayes, Kenneth R. Meehan, Elizabeth A O'Donnell, Aricca Van Citters, Kate L. Caldon, Charlotte M Coughenour, Dorothy R. McKenna, Carla Tarzia, Wenyan Zhao, Kimberley R Holt, Christopher H. Lowrey, John M. Hill, Jr., Tiffany D'Cruze, Megan M Holthoff, Tor Tosteson, Anna Tosteson
Journal: Blood
Blood (2022) 140 (Supplement 1): 8113–8114.
https://doi.org/10.1182/blood-2022-163437
Published: 2022
Journal Articles

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Arvind Suresh, Maeen N. Arslan, Heather A. Wishart, Amy M. Chan, Bryce S. Jacobson, Grant Moncrief, Christopher H. Lowrey, Christi Ann Hayes, Susan C. Brighton, Dorothy R. McKenna, Lisa J. Wesinger, Judi A. Gentes, Kate L. Caldon, Zbigniew M. Szczepiorkowski, Kenneth R. Meehan, John M. Hill, Jr.
Journal: Blood
Blood (2022) 140 (Supplement 1): 4686–4687.
https://doi.org/10.1182/blood-2022-168112
Published: 2022
Journal Articles

Peripheral Blood Chimerism Can Replace Marrow Chimerism Analyses Following Adult Allogeneic Stem Cell Transplant.

Cocav Rauwerdink, MD, Gregory J Tsongalis, PhD, John M. Hill, Jr., MD, Kenneth R Meehan, MD
Journal: Blood
Blood (2009) 114 (22): 4316.
https://doi.org/10.1182/blood.V114.22.4316.4316
Published: 2009
Journal Articles

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Kenneth R Meehan, MD, John M. Hill, Jr., MD, Marc Ernstoff, MD, Charles L Sentman, MD
Journal: Blood
Blood (2008) 112 (11): 3491.
https://doi.org/10.1182/blood.V112.11.3491.3491
Published: 2008